Il y a eu 50 transactions d'initiés récentes enregistrées pour Sutro Biopharma, Inc. (STRO), dont 32 achats et 15 ventes. Le total des achats d'initiés s'élève à $796.23K et le total des ventes d'initiés à $76.16K.
Les initiés notables ayant une activité récente comprennent Chung Jane, Pauling David, Chow Gregory K.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — STRO
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
788 |
- |
- |
- |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Exercice d'Options (Vente) |
675 |
- |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
Attribution de RSU |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
Retenue Fiscale RSU |
2,779 |
$20.55 |
$57.11K |
20,779 |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
Attribution de RSU |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Attribution de RSU |
4,200 |
- |
- |
4,200 |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
688 |
- |
- |
688 |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
Exercice d'Options (Vente) |
1,125 |
- |
- |
2,250 |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Exercice d'Options (Vente) |
500 |
- |
- |
500 |
| 2025-12-23 |
Panek James P |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Matsui Connie |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Petree Daniel H |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Lobacki Joseph M |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Jagpal Sukhi |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Dybbs Michael |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Chow Gregory K. |
CFO |
Attribution de RSU |
8,200 |
$10.38 |
$85.12K |
8,200 |
| 2025-12-23 |
Hunter Heidi |
Director |
Attribution de RSU |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
Attribution de RSU |
7,925 |
$10.38 |
$82.26K |
7,925 |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Attribution de RSU |
7,200 |
$10.38 |
$74.74K |
7,200 |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
2,500 |
- |
- |
5,000 |
| 2025-10-15 |
Matsui Connie |
Director |
Achat Informatif |
50,000 |
$0.80 |
$39.95K |
50,000 |
| 2025-10-15 |
Chow Gregory K. |
CFO |
Achat Informatif |
19,750 |
$0.81 |
$16K |
19,750 |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
Achat Informatif |
12,500 |
$0.80 |
$10.01K |
122,850 |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
Achat Informatif |
17,000 |
$0.80 |
$13.61K |
71,832 |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Achat Informatif |
12,504 |
$0.80 |
$9.99K |
71,737 |
| 2025-09-18 |
Gerber Hans-peter |
Chief Scientific Officer |
Retenue Fiscale RSU |
13,417 |
$0.90 |
$12.08K |
54,832 |
| 2025-08-09 |
Chung Jane |
Chief Executive Officer |
Exercice d'Options (Vente) |
18,750 |
- |
- |
- |
| 2025-07-08 |
Leyman Barbara |
Chief Business Officer |
Retenue Fiscale RSU |
8,944 |
$0.78 |
$6.98K |
16,056 |
| 2025-06-06 |
Panek James P |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Matsui Connie |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Petree Daniel H |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Lobacki Joseph M |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Jagpal Sukhi |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Wigginton Jon Marc |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Dybbs Michael |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Hunter Heidi |
Director |
Attribution de RSU |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-02 |
Chow Gregory K. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-06-02 |
Chow Gregory K. |
CFO |
Attribution de RSU |
100,000 |
- |
- |
100,000 |
| 2025-05-15 |
Albini Edward C |
CFO and Secretary |
Exercice d'Options (Vente) |
9,125 |
- |
- |
- |
| 2025-05-01 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
Exercice d'Options (Vente) |
9,125 |
- |
- |
- |
| 2025-05-01 |
Borgman Anne Elizabeth |
Chief Medical Officer |
Exercice d'Options (Vente) |
15,938 |
- |
- |
17,812 |
| 2025-05-01 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
Exercice d'Options (Vente) |
2,500 |
- |
- |
5,000 |
| 2025-04-11 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
Exercice d'Options (Vente) |
21,250 |
- |
- |
21,250 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Inconnu |
- |
- |
- |
56,733 |
| 2025-04-04 |
Chung Jane |
Chief Executive Officer |
Attribution de RSU |
310,000 |
- |
- |
310,000 |
| 2025-04-04 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
Attribution de RSU |
94,250 |
- |
- |
94,250 |
| 2025-04-04 |
Gerber Hans-peter |
Chief Scientific Officer |
Attribution de RSU |
113,750 |
- |
- |
113,750 |
| 2025-04-04 |
Leyman Barbara |
Chief Business Dev. Officer |
Attribution de RSU |
84,500 |
- |
- |
84,500 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Inconnu |
25,275 |
- |
- |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
